Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity LONDON, Feb 7 — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis